QSimulate is a Cambridge-based quantum molecular simulation company founded in 2018 by Garnet Chan and Toru Shiozaki that develops cloud-based quantum chemical simulation tools for pharmaceutical, materials, and chemical companies. In August 2025, QSimulate partnered with Mitsui & Co. and Quantinuum to launch QIDO (Quantum-Integrated Discovery Orchestrator), a quantum-enabled chemistry platform that integrates QSimulate’s QSP Reaction software with Quantinuum’s InQuanto platform to enable high-precision chemical simulations. The company’s QSP platform enables customers to perform quantum chemical simulations modeling thousands of atoms with state-of-the-art quantum chemistry methods, enabling first-of-a-kind quantum simulations of ligand-protein interactions throughout the computational drug discovery pipeline. QSimulate has raised $11.34 million in total funding including a $2.5 million Series A round in 2023, with strategic partnerships including Japan Tobacco for small molecule drug discovery acceleration.
Garnet Chan (Co-founder), Toru Shiozaki (Co-founder)
Explore other quantum computing companies in similar categories or regions.
Information for Educational Purposes Only: All information about QSimulate is provided for informational and educational purposes only. This is not investment, financial, or professional advice.
No Warranties: While we strive for accuracy, Quantum Zeitgeist makes no warranties regarding the accuracy, completeness, or timeliness of company information. The quantum technology industry evolves rapidly, and information may become outdated.
No Endorsement: Inclusion in Quantum Navigator does not constitute an endorsement, recommendation, or verification of QSimulate's claims, technology, or business viability.
Do Your Own Research: Always conduct independent due diligence and consult qualified professionals (financial advisors, lawyers, etc.) before making investment, business, or career decisions.
For more information, see our Terms of Service and Privacy Policy.